198
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach

, , , , , , , , , & show all
Pages 3689-3711 | Published online: 26 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ravinder Kumar, Vartika Srivastava, Piyush Baindara & Aijaz Ahmad. (2022) Thermostable vaccines: an innovative concept in vaccine development. Expert Review of Vaccines 21:6, pages 811-824.
Read now
Yizhi Qi & Christopher B. Fox. (2021) Development of thermostable vaccine adjuvants. Expert Review of Vaccines 20:5, pages 497-517.
Read now

Articles from other publishers (30)

Yan Li, Guiyan JiaTao Li, Xiechen Zhou, Hui Zhao, Junyang Cao, Zijan Guan & Rui Zhao. (2024) Preparation Optimization and Immunological Activity Studies of Portulaca oleracea L. Polysaccharides Liposomes. Current Pharmaceutical Design 30:10, pages 786-797.
Crossref
Hyunjung Jin, Yuhyun Ji, Jinsu An, Da Hui Ha, Ye‐Ram Lee, Hye‐Ji Kim, Choon Geun Lee, Wooyeon Jeong, Ick Chan Kwon, Eun Gyeong Yang, Ki Hun Kim, Chankyu Lee & Hak Suk Chung. (2024) Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant . Biotechnology and Bioengineering 121:3, pages 1144-1162.
Crossref
Ayushi Nair, Alosh Greeny, Amritasree Nandan, Ranjay Kumar Sah, Anju Jose, Sathish Dyawanapelly, Vijayabhaskarreddy Junnuthula, Athira K. V.Prashant Sadanandan. (2023) Advanced drug delivery and therapeutic strategies for tuberculosis treatment. Journal of Nanobiotechnology 21:1.
Crossref
Alejandra Barrera-Rosales, Romina Rodríguez-Sanoja, Rogelio Hernández-Pando & Silvia Moreno-Mendieta. (2023) The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges. Microorganisms 11:8, pages 1988.
Crossref
William R. Lykins & Christopher B. Fox. (2023) Practical Considerations for Next-Generation Adjuvant Development and Translation. Pharmaceutics 15:7, pages 1850.
Crossref
Riccardo Rampado & Dan Peer. (2023) Design of experiments in the optimization of nanoparticle-based drug delivery systems. Journal of Controlled Release 358, pages 398-419.
Crossref
Michelle C. Archer, Joseph McCollum, Christopher Press, Timothy S. Dutill, Hong Liang, Dawn Fedor, Liam Kapilow-Cohen, Alana Gerhardt, Tony Phan, Edward H. Trappler, Mark T. Orr, Ryan M. Kramer & Christopher B. Fox. (2023) Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine. Heliyon 9:6, pages e17325.
Crossref
Zachary K. Sagawa, Cristina Goman, Aude Frevol, Azra Blazevic, Janice Tennant, Bridget Fisher, Tracey Day, Stephen Jackson, Franck Lemiale, Leon Toussaint, Irene Kalisz, Joe Jiang, Lisa Ondrejcek, Raodoh Mohamath, Julie Vergara, Alan Lew, Anna Marie Beckmann, Corey Casper, Daniel F. Hoft & Christopher B. Fox. (2023) Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults. Nature Communications 14:1.
Crossref
Donatello Laera, Camilla Scarpellini, Simona Tavarini, Barbara Baudner, Agnese Marcelli, Carlo Pergola, Malte Meppen & Derek T. O’Hagan. (2023) Maturation of Aluminium Adsorbed Antigens Contributes to the Creation of Homogeneous Vaccine Formulations. Vaccines 11:1, pages 155.
Crossref
Timothy S. Dutill, Michelle C. Archer, Joseph McCollum, Chris Press, Lisa McNeill, Linda Hawkins, Tony Phan, Erik D. Laursen, Richard Cabullos, Lisa Bouchard, Regie J. Castro, Mong-Wu Lin, Jeralyn Roco, Cecile Blois, Babatunde A. Adeagbo, Jeffrey A. Guderian, Alana Gerhardt, Anna Marie Beckmann, Edward H. Trappler, Ryan M. Kramer & Christopher B. Fox. (2022) Lyophilization process engineering and thermostability of ID93 + GLA-SE, a single-vial adjuvanted subunit tuberculosis vaccine candidate for use in clinical studies. Frontiers in Drug Delivery 2.
Crossref
Zahra Ghaemmaghamian, Reza Zarghami, Gavin Walker, Emmet O’Reilly & Ahmad Ziaee. (2022) Stabilizing vaccines via drying: Quality by design considerations. Advanced Drug Delivery Reviews 187, pages 114313.
Crossref
Alana Gerhardt, Emily Voigt, Michelle Archer, Sierra Reed, Elise Larson, Neal Van Hoeven, Ryan Kramer, Christopher Fox & Corey Casper. (2022) A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery. Molecular Therapy - Methods & Clinical Development 25, pages 205-214.
Crossref
Moein Masjedi, Talieh Montahaei, Zeinab Sharafi & Atefeh Jalali. (2022) Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology 69, pages 103184.
Crossref
Mellissa Gomez, Mushtaq Ahmed, Shibali Das, Joseph McCollum, Leah Mellett, Rosemary Swanson, Ananya Gupta, Nicholas B. Carrigy, Hui Wang, David Barona, Shital Bachchhav, Alana Gerhardt, Chris Press, Michelle C. Archer, Hong Liang, Emilie Seydoux, Ryan M. Kramer, Philip J. Kuehl, Reinhard Vehring, Shabaana A. Khader & Christopher B. Fox. (2022) Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model. Frontiers in Pharmacology 12.
Crossref
Sonia Singh, Yogesh Murti & Nitin Agrawal. 2022. Handbook of Research on Nanoemulsion Applications in Agriculture, Food, Health, and Biomedical Sciences. Handbook of Research on Nanoemulsion Applications in Agriculture, Food, Health, and Biomedical Sciences 169 193 .
Kendall B. Preston, Teri Ann S. Wong, Albert To, Taylor E. Tashiro, Michael M. Lieberman, Alex Granados, Karen Feliciano, John Harrison, Jake Yalley-Ogunro, Hanne Andersen Elyard, Oreola Donini, Axel T. Lehrer & Theodore W. Randolph. (2021) Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant. Vaccine 39:39, pages 5650-5657.
Crossref
Mellissa Gomez, Joseph McCollum, Hui Wang, Shital Bachchhav, Isobel Tetreau, Alana Gerhardt, Chris Press, Ryan M. Kramer, Christopher B. Fox & Reinhard Vehring. (2021) Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery. Vaccine 39:35, pages 5025-5036.
Crossref
Mellissa Gomez, Michelle Archer, David Barona, Hui Wang, Mani Ordoubadi, Shabab Bin Karim, Nicholas B. Carrigy, Zheng Wang, Joseph McCollum, Chris Press, Alana Gerhardt, Christopher B. Fox, Ryan M. Kramer & Reinhard Vehring. (2021) Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying. European Journal of Pharmaceutics and Biopharmaceutics 163, pages 23-37.
Crossref
Kendall B. Preston & Theodore W. Randolph. (2021) Stability of lyophilized and spray dried vaccine formulations. Advanced Drug Delivery Reviews 171, pages 50-61.
Crossref
P Rashmi & BLR Madhavi. (2021) Vaccine development and delivery strategies – A glimpse. Journal of Vaccines and Immunology, pages 004-008.
Crossref
Mellissa Gomez, Joseph McCollum, Hui Wang, Mani Ordoubadi, Chester Jar, Nicholas B. Carrigy, David Barona, Isobel Tetreau, Michelle Archer, Alana Gerhardt, Chris Press, Christopher B. Fox, Ryan M. Kramer & Reinhard Vehring. (2021) Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate. International Journal of Pharmaceutics 593, pages 120121.
Crossref
Babatunde Ayodeji Adeagbo, Akintunde Oluseto Akinlalu, Tony Phan, Jeff Guderian, Gerhardt Boukes, Elize Willenburg, Caryn Fenner, Oluseye Oladotun Bolaji & Christopher B. Fox. (2020) Controlled Covalent Conjugation of a Tuberculosis Subunit Antigen (ID93) to Liposome Improved In Vitro Th1-Type Cytokine Recall Responses in Human Whole Blood . ACS Omega 5:48, pages 31306-31313.
Crossref
Matheus Aparecido dos Santos Ramos, Karen Cristina dos Santos, Patrícia Bento da Silva, Luciani Gaspar de Toledo, Gabriel Davi Marena, Camila Fernanda Rodero, Bruna Almeida Furquim de Camargo, Giovanna Capaldi Fortunato, Taís Maria Bauab & Marlus Chorilli. (2020) Nanotechnological strategies for systemic microbial infections treatment: A review. International Journal of Pharmaceutics 589, pages 119780.
Crossref
Lucas S. Shores, Sean H. Kelly, Kelly M. Hainline, Jutamas Suwanpradid, Amanda S. MacLeod & Joel H. Collier. (2020) Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis. Frontiers in Immunology 11.
Crossref
Derek T. O’Hagan, Rushit N. Lodaya & Giuseppe Lofano. (2020) The continued advance of vaccine adjuvants – ‘we can work it out’. Seminars in Immunology 50, pages 101426.
Crossref
Tony Phan, Christian Devine, Erik D. Laursen, Adrian Simpson, Aaron Kahn, Amit P. Khandhar, Steven Mesite, Brad Besse, Ken J. Mabery, Elizabeth I. Flanagan & Christopher B. Fox. (2020) Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response. Pharmaceuticals 13:8, pages 168.
Crossref
Barbara K. Felber, Zhongyan Lu, Xintao Hu, Antonio Valentin, Margherita Rosati, Christopher A.L. Remmel, Joshua A. Weiner, Margaret C. Carpenter, Katelyn Faircloth, Sherry Stanfield-Oakley, Wilton B. Williams, Xiaoying Shen, Georgia D. Tomaras, Celia C. LaBranche, David Montefiori, Hung V. Trinh, Mangala Rao, Munir S. Alam, Nathan A. Vandergrift, Kevin O. Saunders, Yunfei Wang, Wes Rountree, Jishnu Das, Galit Alter, Steven G. Reed, Pyone P. Aye, Faith Schiro, Bapi Pahar, Jason P. Dufour, Ronald S. Veazey, Preston A. Marx, David J. Venzon, George M. Shaw, Guido Ferrari, Margaret E. Ackerman, Barton F. Haynes & George N. Pavlakis. (2020) Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge. Cell Reports 31:6, pages 107624.
Crossref
Aneesh Thakur & Camilla Foged. 2020. Nanoengineered Biomaterials for Advanced Drug Delivery. Nanoengineered Biomaterials for Advanced Drug Delivery 603 646 .
Yangjie Wei, Sangeeta B. Joshi, Akhilesh Bhambhani, Yuhong Zeng, Nicholas R. Larson, Gang Hu, Eric J. Deeds & C. Russell Middaugh. 2020. Development of Biopharmaceutical Drug-Device Products. Development of Biopharmaceutical Drug-Device Products 139 185 .
Steven G. Reed, Darrick Carter, Corey Casper, Malcolm S. Duthie & Christopher B. Fox. (2018) Correlates of GLA family adjuvants’ activities. Seminars in Immunology 39, pages 22-29.
Crossref